Product image of Modafinilo Aurovitas (Modafinil) supplied by GNH India

Modafinilo Aurovitas

Active Ingredient:
Modafinil
Origin:
EU

Modafinilo Aurovitas (Modafinil)

Modafinil, the active ingredient in Modafinilo Aurovitas, is a eugeroic (wakefulness‑promoting agent) presented as an oral tablet for oral use. It is indicated for the treatment of excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorder.

GNH India supplies Modafinilo Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing reliable distribution across multiple regions.

Manufacturer / TM Owner

Aurovitas Spain,s.A.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Modafinil is a central nervous system stimulant used to improve wakefulness in sleep‑related disorders.
  • Narcolepsy: reduces excessive daytime sleepiness and improves alertness in patients with narcolepsy.
  • Obstructive sleep apnea (OSA): alleviates residual daytime sleepiness when used alongside standard OSA therapy.
  • Shift work disorder: helps maintain alertness during scheduled work hours for individuals with shift‑work disorder.

How It Works

  • Modafinil promotes wakefulness primarily by inhibiting dopamine reuptake, thereby increasing extracellular dopamine levels. It also activates hypothalamic orexin neurons and modulates histamine, norepinephrine, and serotonin pathways, collectively enhancing cortical arousal and reducing sleep propensity.

Side Effects

Common Side Effects

  • Headache
  • Nausea
  • Insomnia
  • Dry mouth

Serious or Rare Side Effects

  • Severe rash or Stevens‑Johnson syndrome
  • Psychiatric disturbances such as hallucinations or depression
  • Cardiovascular events including hypertension or arrhythmia

Precautions & Warnings

Before initiating therapy, consider the following precautions:

  • Assess cardiovascular status: evaluate blood pressure and heart rhythm.
  • Review psychiatric history: avoid in patients with uncontrolled psychosis.
  • Consider hepatic function: dose may need adjustment in severe liver impairment.
  • Avoid concomitant use with potent CYP3A4 inhibitors: may increase plasma levels.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Modafinil may interact with several medicines; careful assessment is required.

Major Interactions (Avoid)

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can markedly increase modafinil concentrations.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine): can reduce efficacy by lowering drug levels.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: modafinil may reduce hormonal efficacy; consider alternative contraception.
  • Antidepressants (e.g., SSRIs, SNRIs): may increase risk of serotonin syndrome.
  • Antihypertensives: modafinil may diminish blood pressure control; monitor blood pressure regularly.

Frequently Asked Questions

Modafinilo Aurovitas contains modafinil, a wakefulness‑promoting agent prescribed to reduce excessive daytime sleepiness in conditions such as narcolepsy, obstructive sleep apnea, and shift‑work disorder.

Modafinil works by inhibiting dopamine reuptake, which raises extracellular dopamine levels, and by activating orexin neurons in the hypothalamus. It also influences histamine, norepinephrine, and serotonin pathways, collectively enhancing alertness and reducing the drive to sleep.

The appropriate dose of Modafinilo Aurovitas is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and any relevant safety considerations.

Safety data for modafinil in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks before prescribing to pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Modafinil differs from traditional stimulants such as methylphenidate by having a lower risk of cardiovascular stimulation and a longer duration of action. It is often preferred for patients who need sustained wakefulness with fewer sympathomimetic effects.

Store Modafinilo Aurovitas at ambient temperature below 25 °C, in the original packaging, and protect it from moisture and direct sunlight to maintain product stability.

Modafinilo Aurovitas is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, psychiatric disturbances like hallucinations or depression, and cardiovascular events such as hypertension or arrhythmias. Patients should seek immediate medical attention if any of these occur.

Individuals with known hypersensitivity to modafinil, uncontrolled hypertension, severe psychiatric disorders, or those taking contraindicated CYP3A4 inhibitors should avoid using Modafinilo Aurovitas unless advised otherwise by a clinician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.